dr. nasser altorki: neoadjuvant immunotherapy and radiation boosts response in nsclc
Published 1 month ago • 191 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:06:01
drs. altorki & spicer discuss immunotherapy advances in stage i-iii nsclc: https://bit.ly/3hvzzoz
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc
-
59:47
drs. altorki & spicer discuss the latest #nsclc updates from #aats2022 - https://bit.ly/3wqcc2g
-
11:12
for nsclc neoadjuvant adjuvant or both
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
0:59
dr. weksler on neoadjuvant and adjuvant therapy in nsclc
-
2:28
clinical trials of neoadjuvant targeted therapy in resectable nsclc
-
0:59
dr. johung on prognosis of patients with alk-rearranged nsclc and brain metastases
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
3:59
emerging therapies and combinations for alk-mutant nsclc
-
8:06
adaura: osimertinib post-tumor resection in nsclc
-
3:52
keynote 10: pembrolizumab vs docetaxel for nsclc
-
0:39
continuation of ceritinib beyond disease progression in alk-positive nsclc
-
1:06:05
neo-adjuvant therapy of resectable lung cancer
-
1:18
exploring neoadjuvant egfr-tkis in lung cancer
-
2:20
radiosurgery at the palo alto medical foundation
-
4:05
arrow: precision targeted therapy with pralsetinib for ret fusion tumors